A Study to Assess the Safety, Tolerability and Efficacy of RG2417 in Bipolar I Depression

Clinical trial NCT00812058 · COMPLETED

Trial details

NCT number: NCT00812058
Sponsor: Repligen Corporation
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Bipolar I Depression

Start date: 2008-11-01
Primary completion: 2010-12-01
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.